Citron Still Thinks Mobileye Is Way Overvalued

By: via Benzinga
Noted short-selling arm, Citron Research, has not pulled any punches on Mobileye NV (NYSE: MBLY). Left: Stock Still Way ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.